Influence of Qiantongding Prescription on Monoamine Neurotransmitters in Blood Plasma of Type Ⅲ Chronic Prostatitis Patients

洪志明,王全,黎杰运,陈德宁,周文彬,黄忠旺

DOI: https://doi.org/10.13194/j.issn.1673-842x.2013.10.066

2013-01-01

Abstract:Objective:To observe the impacts of Qiantongding Prescription on the monoamine neurotransmitters in the blood plasma of Type III chronic prostatitis(CP) patients.Methods:120 cases of Type HI CP patients were randomized into three groups.Among them,those in the Group 1 were orally treated with Qiantongding Prescription,those in the Group 2 were orally treated with Cardura tablets,and those in the Group 3 were orally treated with Qiantongding Prescription plus Cardura tablets,with thirty days as the therapeutic session.Before and after treatments,all the patients were assessed with the NIH—CPSI score,and the contents of the monoamine neurotransmitters such as NE,5-HT and DA in the blood plasma were detected with ELISA methods.Results:Before treatments,the characteristic of baseline among the three groups was good(P>0.05).After the treatments,the NIH-CPSI score and the contents of NE and DA in the blood plasma were increased,and those in the Group 3 were better than those in the other two groups(P<0.05).Conclusion:Qiantongding Prescription could obviously reduce the NIH—CPSI scores of the Type III CP patients,regulate the abnormal contents of monoamine neurotransmitters in the blood plasma and remarkably improve the clinical symptoms.